Rain Therapeutics (RAIN) PT Raised to $12 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts RAIN Hot Sheet
Price: $2.21 -4.74%
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
H.C. Wainwright analyst Mitchell Kapoor raised the price target on Rain Therapeutics (NASDAQ: RAIN) to $12.00 (from $10.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Nomura/Instinet Downgrades T&D Holdings Inc (8795:JP) (TDHOY) to Neutral
- BorgWarner (BWA) PT Raised to $95 at Wolfe Research, 'Bullish Takeaways from CEO Meetings'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
